VALEANT INTERNATIONAL (BARBADOS) SRL

10BENZAGEL

IN THE STATEMENT, COLUMN 1, LINE 1 (NEW YORK CORPORATION) SHOULD BE DELETED AND (DELAWARE CORPORATION) SHOULD BE INSERTED.;AID IN THE TREATMENT OF ACNE;APPLICANT DISCLAIMS ANY EXCLUSIVE RIGHT TO THE NUMERAL 10 APART FROM THE MARK AS SHOWN.;10-BENZAGEL;

5 BENZAGEL

AID IN THE TREATMENT OF ACNE;

BENZAGEL WASH

Pharmaceutical preparation for the treatment of skin disorders;WASH;

BENZAGELWASH

Pharmaceutical preparation for the treatment of skin disorders;

BIAFINESUN

Medicated sun care preparations, namely, topical preparations for sun protection, for treating sunburn and for treating sun-damaged skin;Non-medicated cosmetic and toiletry skin care preparations for tanning and sun protection; skin moisturizers and pre- and post-sun skin creams and lotions;

CICABIAFINE

Facial skin creams, skin lotions, skin moisturizers, skin toners, skin cleansers; body lotions; hand cream; anti-wrinkle cream;

CLINDA-PAK

pharmaceutical preparation for the treatment of skin disorders;CLINDA PACK;

GRIFULVIN

ANTIBIOTIC AND ANTIFUNGAL PRODUCTS FOR PERSONAL USE;

INSTATAB

Pharmaceutical preparations and substances for the prevention, treatment and alleviation of stress; pharmaceutical preparations and substances for the prevention, treatment and alleviation of diabetes; pharmaceutical preparations and substances for controlling insulin levels; pharmaceutical preparations and substances for the prevention, treatment and alleviation of hypertension; pharmaceutical preparations and substances for the prevention, treatment and alleviation of angina; pharmaceutical preparations and substances for the cessation of smoking; pharmaceutical preparations and substances for the prevention and treatment of sexually transmitted diseases; pharmaceutical preparations and substances for the prevention and treatment of herpes; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the central nervous system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of depression; anti-depressants; pharmaceutical preparations and substances for the prevention, treatment and alleviation of sleep disorders; pharmaceutical preparations and substances for the prevention, treatment and alleviation of anxiety; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the cardio-vascular system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of acute myocardial infarctions; pharmaceutical preparations and substances for the prevention, treatment and alleviation of symptomatic congestive heart failure; pharmaceutical preparations and substances for the prevention, treatment and alleviation of asymptomatic left ventricular dysfunction; pharmaceutical preparations and substances, namely, fibrinolytic or thrombolytic agents; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the respiratory system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the endocrine system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the immune system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the musculo-skeletal system, namely, bone diseases and bone degenerative conditions; pharmaceutical preparations and substances for the prevention, treatment and alleviation of pain and inflammation, namely, pain relief medication and anti-inflammatories; pharmaceutical preparations and substances for the prevention, treatment and alleviation of migraines; pharmaceutical preparations and substances, namely, medicated skin care preparations for use in dermatology, namely, dermatitis and skin pigmentation diseases; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations and substances for use in ophthalmology; pharmaceutical preparations and substances for the treatment of polycystic ovary syndrome; pharmaceutical preparations and substances for the treatment of infertility; pharmaceutical preparations and substances for the prevention, treatment and alleviation of circulatory, neurologic, alimentary, auto-immune, pulmonary, musculoskeletal, lymphatic, gastrointestinal, bone sensory, viral, urinary, renal, infectious or metabolic diseases, illnesses, disorders or conditions;Color is not claimed as a feature of the mark.;

M

The mark consists of Capital M with image to the right of the M of side view of human face.;pharmaceutical preparations for skin care;cosmetic preparations for skin care, namely peel solution;Color is not claimed as a feature of the mark.;